Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -33.04x is 11% above its 5-year average of -37.14x, near the high end of its 5-year range (-646.00x–-14.12x).
As of the fiscal period ended Thursday, June 30, 2022. 61.43% below its 12-month average of -20.47x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2022 (2022-06-30): -33.04x.
INTEREST COVERAGE RATIO
-33.04x
INTEREST COVERAGE RATIO AVG TTM
-20.47x
INTEREST COVERAGE RATIO AVG 3Y
-60.34x
INTEREST COVERAGE RATIO AVG 5Y
-37.14x
INTEREST COVERAGE RATIO AVG 10Y
-36.72x
INTEREST COVERAGE RATIO AVG 15Y
-97.63x
INTEREST COVERAGE RATIO AVG 20Y
-160.72x
CURRENT VS TTM AVG
-61.43%
CURRENT VS 3Y AVG
+45.24%
CURRENT VS 5Y AVG
+11.05%
CURRENT VS 10Y AVG
+10.03%
CURRENT VS 15Y AVG
+66.16%
CURRENT VS 20Y AVG
+79.44%
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-413.02%
vs the sector median at left
Savara Inc.
Market Cap
$952.91M
Interest Coverage Ratio
-33.04x
TTM Avg
-20.47x
3Y Avg
-60.34x
5Y Avg
-37.14x
Market Cap
$953.81M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$934.79M
Interest Coverage Ratio
-200.81x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$973.93M
Interest Coverage Ratio
2.28x
TTM Avg
2.28x
3Y Avg
3.01x
5Y Avg
2.79x
Market Cap
$929.83M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$978.09M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$981.66M
Interest Coverage Ratio
-8.69x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$923.53M
Interest Coverage Ratio
-30.90x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$982.46M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Savara Inc. (SVRA) | $952.91M | -33.04x | -20.47x | -60.34x | -37.14x |
| Aktis Oncology, Inc. (AKTS)vs › | $953.81M | N/A | N/A | N/A | N/A |
| Kura Oncology, Inc. (KURA)vs › | $934.79M | -200.81x | N/A | N/A | N/A |
| Pacira BioSciences, Inc. (PCRX)vs › | $973.93M | 2.28x | 2.28x | 3.01x | 2.79x |
| Seaport Therapeutics, Inc. Common Stock (SPTX)vs › | $929.83M | N/A | N/A | N/A | N/A |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $978.09M | N/A | N/A | N/A | N/A |
| MeiraGTx Holdings plc (MGTX)vs › | $981.66M | -8.69x | N/A | N/A | N/A |
| CeriBell, Inc. (CBLL)vs › | $923.53M | -30.90x | N/A | N/A | N/A |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $982.46M | N/A | N/A | N/A | N/A |
| MoonLake Immunotherapeutics (MLTX)vs › | $921.06M | -33.78x | N/A | N/A | N/A |
Interest Coverage
-33.0x
Debt/Equity
0.21
Current Ratio
10.13
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2022-06-30 | -33.04x |
| 2022-03-31 | -14.12x |
| 2021-12-31 | -18.83x |
| 2021-09-30 | -17.62x |
| 2021-06-30 | -18.73x |
| 2021-03-31 | -17.56x |
| 2020-12-31 | -24.55x |
| 2020-09-30 | -23.50x |
| 2020-06-30 | -27.90x |
| 2020-03-31 | -101.50x |
| 2019-12-31 | -366.38x |
| 2019-03-31 | -646.00x |
| 2018-06-30 | -105.37x |
| 2018-03-31 | -308.72x |
| 2017-12-31 | -75.58x |
| 2017-09-30 | -23.62x |
| 2017-06-30 | -18.11x |
| 2017-03-31 | -32.01x |
| 2016-12-31 | -54.20x |
| 2016-09-30 | -7.60x |
| 2016-06-30 | -19.96x |
| 2016-03-31 | -20.70x |
| 2015-12-31 | -19.39x |
| 2015-09-30 | -97.31x |
| 2015-06-30 | -10181.00x |
| 2012-03-31 | -389.50x |
| 2011-12-31 | -227.52x |
| 2011-09-30 | -13062.50x |
| 2010-12-31 | -4095.49x |
| 2010-09-30 | -3824.91x |
| 2010-06-30 | -2678.11x |
| 2010-03-31 | -1485.50x |
| 2009-12-31 | 73.28x |
| 2005-03-31 | -9606.52x |
| 2004-12-31 | -1743.02x |
| 2003-12-31 | -698.42x |
| 2003-09-30 | -2301.86x |
| 2002-12-31 | -1.73x |
